Antiviral activity of recombinant rat interferon gamma in immunologically impaired and immunosuppressed rats
- PMID: 2841410
- DOI: 10.1099/0022-1317-69-8-1979
Antiviral activity of recombinant rat interferon gamma in immunologically impaired and immunosuppressed rats
Abstract
Treatment of Wag/Rij rats with recombinant rat interferon gamma (rRIF-gamma) resulted in complete protection against a lethal pseudorabies virus (PRV) infection. To investigate whether the protection resulted from direct inhibition of virus replication or from a stimulation of immune mechanisms, we tested rRIF-gamma activity in naturally immunocompromised and artificially immunosuppressed rats. The antiviral effect of rRIF-gamma was not abolished in silica- and carrageenan-treated, phagocyte-depleted rats. Immunologically immature newborn and T cell-deficient nude rats were also protected under a regime of rRIF-gamma treatment as well as whole body gamma-irradiated rats. Sera of the protected rats were devoid of PRV-neutralizing antibodies. Our results indicate that the protective activity of rRIF-gamma is based on direct inhibition of virus replication; stimulation of the immune system is not required but may be responsible for protection upon challenge several weeks after infection.
Similar articles
-
Protection of rats against pseudorabies virus infection by gamma-interferon.Proc Soc Exp Biol Med. 1989 Oct;192(1):47-55. doi: 10.3181/00379727-192-42954. Proc Soc Exp Biol Med. 1989. PMID: 2552453
-
Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.Vet Immunol Immunopathol. 2004 May;99(1-2):113-25. doi: 10.1016/j.vetimm.2004.01.004. Vet Immunol Immunopathol. 2004. PMID: 15113659
-
Limited protection conferred by a DNA vaccine against a lethal pseudorabies virus infection at day 5 postvaccination.Clin Vaccine Immunol. 2007 Apr;14(4):470-3. doi: 10.1128/CVI.00428-06. Epub 2007 Feb 14. Clin Vaccine Immunol. 2007. PMID: 17301217 Free PMC article.
-
Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells.J Gen Virol. 1991 Apr;72 ( Pt 4):809-15. doi: 10.1099/0022-1317-72-4-809. J Gen Virol. 1991. PMID: 1849968
-
The co-administrating of recombinant porcine IL-2 could enhance protective immune responses to PRV inactivated vaccine in pigs.Vaccine. 2005 Aug 15;23(35):4436-41. doi: 10.1016/j.vaccine.2005.03.034. Vaccine. 2005. PMID: 15946776
Cited by
-
Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon.J Virol. 1996 Apr;70(4):2247-51. doi: 10.1128/JVI.70.4.2247-2251.1996. J Virol. 1996. PMID: 8642649 Free PMC article.
-
Animal models in interferon research: some current trends.Experientia. 1989 Jun 15;45(6):558-62. doi: 10.1007/BF01990506. Experientia. 1989. PMID: 2472290 Review. No abstract available.
-
Immunity to viruses.Curr Opin Immunol. 1989-1990 Feb;2(3):347-52. doi: 10.1016/0952-7915(89)90140-4. Curr Opin Immunol. 1989. PMID: 2483882 Free PMC article. Review. No abstract available.
-
Suppression of rat cytomegalovirus replication by antibodies against gamma interferon.J Virol. 1994 Apr;68(4):2305-12. doi: 10.1128/JVI.68.4.2305-2312.1994. J Virol. 1994. PMID: 8139015 Free PMC article.
-
Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice.Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3409-13. doi: 10.1073/pnas.89.8.3409. Proc Natl Acad Sci U S A. 1992. PMID: 1565633 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources